Figure 7. Kaplan-Meier survival analyses for NSCLC patients with low CTHRC1 expression versus high CTHRC1 expression.

(A) The cumulative overall survival differences between patients with high and low CTHRC1 expression. (B) and (C) Statistical significance of the difference between curves of CTHRC1 high-expressing and low-expressing patients was compared in adenocarcinoma (B) and squamous cell carcinoma (C) patient subgroups. P values were calculated according to the log-rank test.